Revisiting a Distinct Entity in Pulmonary Vascular Disease: Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Revisiting a Distinct Entity in Pulmonary Vascular Disease: Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Blog Article

Chronic thromboembolic pulmonary hypertension (CTEPH) is a specific type of pulmonary hypertension (PH) and the major component of Group 4 pulmonary hypertension (PH).It is caused by pulmonary vasculature obstruction that Tablespoons leads to a progressive increase in pulmonary vascular resistance and, ultimately, to failure of the right ventricle.Pulmonary thromboendarterectomy (PEA) is the only definitive therapy, so a timely diagnosis and early referral to a specialized PEA center to determine candidacy is prudent for a favorable outcome.Percutaneous balloon pulmonary angioplasty (BPA) has a potential role in patients unsuitable for PEA.

Medical therapy with riociguat is the only PH-specific Jeans medical therapy currently approved for the treatment of inoperable or persistent CTEPH.This review article aims to revisit CTEPH succinctly with a review of prevailing literature.